OM

1 Day 1D

5 Days 5D

1 Month 1M

6 Months 6M

YTD YTD

1 Year 1Y

5 Years 5Y

About Outset Medical Inc

Outset is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The Tablo Hemodialysis System, FDA cleared for use from the hospital to the home, represents a significant technological advancement that transforms the dialysis experience for patients and operationally simplifies it for providers. Tablo serves as a single enterprise solution that can be utilized across the continuum of care, allowing dialysis to be delivered anytime, anywhere and by anyone. The integration of water purification and on-demand dialysate production enables Tablo to serve as a dialysis clinic on wheels, with 2-way wireless data transmission and a proprietary data analytics platform powering a new holistic approach to dialysis care. Tablo is a registered trademark of Outset Medical, Inc.
CEO
Employees
313
Headquarters

News

ROSEN, RESPECTED INVESTOR COUNSEL, Encourages Outset Medical, Inc. Investors With Losses to Inquire About Securities Class Action Investigation – OM
Aug 18, 2023 22:36pm

NEW YORK, Aug. 18, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues its investigation of potential securities claims on behalf of shareholders of Outset Medical, Inc. (NASDAQ: OM) resulting from allegations that Outset Medical may have issued materially misleading business information to the investing public.


Source:GlobeNewswire
ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Encourages Outset Medical, Inc. Investors to Inquire About Securities Class Action Investigation - OM
Aug 17, 2023 19:48pm

NEW YORK, Aug. 17, 2023 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Outset Medical, Inc. (NASDAQ: OM) resulting from allegations that Outset Medical may have issued materially…


Source:PR Newswire
CL King initiates coverage of Outset Medical at ''neutral''
Aug 17, 2023 12:17pm

https://www.investing.com/news/pro/outset-medical-inc-receives-investment-bank-analyst-rating-update-3156489


Source:Investing.com
Outset Medical, Inc. 2023 Q2 - Results - Earnings Call Presentation
Aug 10, 2023 14:53pm

The following slide deck was published by Outset Medical, Inc.


Source:Seeking Alpha
Outset Medical halts TabloCart shipments after receiving FDA warning letter
Aug 07, 2023 14:04pm

Outset Medical halts TabloCart shipments after receiving FDA warning letter apark Mon, 08/07/2023 - 10:04


Source:FierceBiotech
INVESTOR ACTION NOTICE: The Schall Law Firm Proclaims it’s Investigating Claims Against Outset Medical, Inc. and Encourages Investors with Losses to Contact the Firm
Aug 05, 2023 21:20pm

LOS ANGELES, CA / ACCESSWIRE / August 5, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, proclaims that it’s investigating claims on behalf of investors of Outset Medical, Inc. (“Outset Medical” or “the Company”) (NASDAQ: OM) for violations of the securities laws. The investigation focuses on whether the Company issued false […] The post INVESTOR ACTION NOTICE: The Schall Law Firm Proclaims it’s Investigating Claims Against Outset Medical, Inc. and Encourages Investors with Losses to Contact the Firm appeared first on TodaysStocks.com .


Source:TodaysStocks.com
ROSEN, A LEADING AND RANKED FIRM, Encourages Outset Medical, Inc. Investors to Inquire About Securities Class Action Investigation – OM
Aug 05, 2023 15:08pm

NEW YORK, Aug. 05, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Outset Medical, Inc. (NASDAQ: OM) resulting from allegations that Outset Medical may have issued materially misleading business information to the investing public.


Source:GlobeNewswire
Outset Medical Stock Tumbles After Shipment Pause Of TabloCart - Here''s Why
Aug 03, 2023 17:39pm

In its Q2 earnings release, Outset Medical Inc (NASDAQ: OM ) announced it has paused the shipment of TabloCart with Prefiltration, an accessory for the Tablo System, pending the FDA''s clearance of a 510(k) the company plans to submit later this month . "Since receiving the Warning Letter on July 6, we have made the decision to file a 510(k) for TabloCart with Prefiltration and pause distribution of the product until a 510(k) clearance … Full story available on Benzinga.com


Source:Benzinga
Outset Medical, Inc. (OM) Q2 2023 Earnings Call Transcript
Aug 03, 2023 00:34am

Outset Medical, Inc. (NASDAQ:NASDAQ:OM) Q2 2023 Earnings Conference Call August 2, 2023 5:00 PM ETCompany ParticipantsJim Mazzola - Vice President, Investor RelationsLeslie Trigg - Chair…


Source:Seeking Alpha
A Preview Of Outset Medical''s Earnings
Aug 01, 2023 18:01pm

Outset Medical (NASDAQ: OM ) is set to give its latest quarterly earnings report on Wednesday, 2023-08-02. Here''s what investors need to know before the announcement. Analysts estimate that Outset Medical will report an earnings per share (EPS) of $-0.73. Outset Medical bulls will hope to hear the company announce they''ve not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the … Full story available on Benzinga.com


Source:Benzinga